<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03594032</url>
  </required_header>
  <id_info>
    <org_study_id>2018-62-K46</org_study_id>
    <nct_id>NCT03594032</nct_id>
  </id_info>
  <brief_title>Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria</brief_title>
  <official_title>Prevalence and Clinical Characteristics of Patients With Bronchiectasis With Comorbid Nontuberculous Mycobacteria Among Middle-aged and Old Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bin Cao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to Understand the prevalence of non-tuberculous
      mycobacterial(NTM) infections in the middle-aged and old women patients with bronchiectasis
      in Mainland China, and explore the characteristics of patients with bronchiectasis comorbid
      NTM.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The development of bronchiectasis is closely related to chronic infection of pathogenic
      microorganisms .Bronchiectasis and nontuberculous mycobacterial (NTM) infections are
      inextricably linked Pathophysiologically. But the incidence rate and characteristics of NTM
      infections among patients with bronchiectasis remains unclear in mainland China.

      In this study, we will collect data of participants about demographic ,co-morbidities
      ,spirometry, mMRC score ,exacerbation history, QOL-B questionnaire, aetiology, spirometry ,
      HRCT(or CT) scan ,results of microbiology samples and treatments, collect three consecutive
      sputum(or induced sputum) samples to smear, bacteria culture, acid-fast stain, mycobacterium
      cultivation and identification, drug susceptibility testing of nontuberculous mycobacteria.To
      estimate the prevalance of non-tuberculous mycobacterial(NTM) infections in Middle-aged and
      old women patients with bronchiectasis in northern China. To analyze clinical manifestations
      and microbiological characteristics of patients with bronchiectasis comorbid NTM infections
      By 16SRNA and gene sequencing.

      In addition, A cross-sectional investigation about lung function and clinical data will be
      done among patients who have confirmed bronchiectasis with NTM from February 2017 to December
      2020.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 14, 2018</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NTM infection rates</measure>
    <time_frame>24 months afer enrolled participants</time_frame>
    <description>NTM infection rates in Middle-aged and old women patients with bronchiectasis in northern China</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical characteristics of patients with bronchiectasis comorbid NTM infections</measure>
    <time_frame>24 months afer enrolled participants</time_frame>
    <description>clinical manifestations of patients with bronchiectasis comorbid NTM infections</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>microbiological characteristics of patients with bronchiectasis comorbid NTM infections</measure>
    <time_frame>24 months afer enrolled participants</time_frame>
    <description>microbiological characteristics of patients with bronchiectasis comorbid NTM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug resistance of NTM</measure>
    <time_frame>24 months afer enrolled participants</time_frame>
    <description>drug susceptibility testing outcomes of nontuberculous mycobacteria from sputum samples</description>
  </secondary_outcome>
  <enrollment type="Anticipated">216</enrollment>
  <condition>Bronchiectasis</condition>
  <condition>Non-tuberculous Mycobacterial</condition>
  <eligibility>
    <study_pop>
      <textblock>
        216 patients with bronchiectasis who meet the below inclusion criteria will be re cruited
        in China-Japan Friendship Hospital in Beijing,China.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Middle-aged and old women who are &gt; or = 50 years of age

          2. Patients meet the criteria of bronchiectasis

        Exclusion Criteria:

          1. Cystic fibrosis

          2. After organ transplantation

          3. Activity tumor (malignant solid tumor and blood system tumor)

          4. Pulmonary interstitial fibrosis with bronchus dilation

          5. Allergic bronchopulmonary aspergillosis

          6. Diffuse panbronchiolitis

          7. Patients refused to sign the informed consent

          8. Patients unable to return sputum specimens
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ben Cao, MD</last_name>
    <role>Study Chair</role>
    <affiliation>China-Japan Friendship Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hongjun Yin, MD</last_name>
    <phone>86 13621089726</phone>
    <phone_ext>861084206250</phone_ext>
    <email>yhjh1101@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ben Cao, MD</last_name>
    <phone>86-010-84206264</phone>
    <phone_ext>8601084206264</phone_ext>
    <email>caobin_ben@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Cao, MD</last_name>
      <phone>86-010-84206264</phone>
      <email>caobin_ben@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Hongjun Yin, MD</last_name>
      <phone>86 13621089726</phone>
      <email>yhjh1101@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Bin Cao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hongjun Yin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 11, 2018</study_first_submitted>
  <study_first_submitted_qc>July 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2018</study_first_posted>
  <last_update_submitted>December 31, 2019</last_update_submitted>
  <last_update_submitted_qc>December 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Bin Cao</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <keyword>bronchiectasis</keyword>
  <keyword>NTM infections</keyword>
  <keyword>Middle-aged and old women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

